TYRA Tyra Biosciences, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Tyra Biosciences, Inc. (TYRA) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 2, 2026, a 10-Q quarterly report filed on November 5, 2025, an 8-K current report filed on April 17, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Tyra Biosciences, Inc. (TYRA) (SEC CIK 1863127), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 8.01: Other Events
- • Equity raise: 4,000,000 shares sold at $31.50/share to a single large institutional buyer via block transaction
- • Gross proceeds $126.0M before fees, executed under existing ATM program registered May 2025
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Tyra Biosciences, Inc. (TYRA) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Profitability | |||||
| Operating Income | -$26.3M | -$58.9M | -$79.9M | -$104.2M | -$132.8M |
| Net Income | -$26.3M | -$55.3M | -$69.1M | -$86.5M | -$119.9M |
| Balance Sheet | |||||
| Total Assets | $306.7M | $266.2M | $225.9M | $363.6M | $282.6M |
| Equity | $301.7M | $257.8M | $204.3M | $343.2M | $259.2M |
| ROE | -8.7% | -21.5% | -33.8% | -25.2% | -46.3% |
Source: XBRL financial data from Tyra Biosciences, Inc. (TYRA) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 17, 2026 | — | — | — |
8-K | Apr 2, 2026 | — | — | — |
8-K | Mar 4, 2026 | — | Analysis | — |
8-K | Mar 2, 2026 | — | Analysis | — |
10-K | Mar 2, 2026 | Dec 31, 2025 | — | |
8-K | Dec 1, 2025 | — | — | |
10-Q | Nov 5, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 14, 2025 | Jun 30, 2025 | — | |
10-Q | May 8, 2025 | Mar 31, 2025 | — | |
10-K | Mar 27, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 7, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 7, 2024 | Jun 30, 2024 | — | |
10-Q | May 9, 2024 | Mar 31, 2024 | — | |
10-K | Mar 19, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 7, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 10, 2023 | Jun 30, 2023 | — | |
10-Q | May 4, 2023 | Mar 31, 2023 | — | |
10-K | Mar 22, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 3, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 4, 2022 | Jun 30, 2022 | — | |
10-Q | May 5, 2022 | Mar 31, 2022 | — | |
10-K | Mar 3, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 3, 2021 | Sep 30, 2021 | — |
Frequently Asked Questions
What are the latest TYRA SEC filings in 2026?
Tyra Biosciences, Inc. (TYRA) has filed a 10-K annual report on March 2, 2026, a 10-Q quarterly report on November 5, 2025, an 8-K current report on April 17, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did TYRA file its most recent 10-K annual report?
Tyra Biosciences, Inc. (TYRA) filed its most recent 10-K annual report on March 2, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view TYRA 10-Q quarterly reports?
Tyra Biosciences, Inc. (TYRA)'s most recent 10-Q quarterly report was filed on November 5, 2025. SignalX displays every TYRA 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has TYRA filed recently?
Tyra Biosciences, Inc. (TYRA)'s most recent 8-K was filed on April 17, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find TYRA insider trading activity (Form 4)?
SignalX aggregates every TYRA Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does TYRA file with the SEC?
Tyra Biosciences, Inc. (TYRA) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new TYRA filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Tyra Biosciences, Inc. (TYRA).
What is TYRA's SEC CIK number?
Tyra Biosciences, Inc. (TYRA)'s SEC CIK (Central Index Key) number is 1863127. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1863127 to look up all TYRA filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find TYRA return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Tyra Biosciences, Inc. (TYRA) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Tyra Biosciences, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 23+ filings.